![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1340, 2011-01, pp. : 14-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Infliximab: Optic neuritis: case report
Reactions Weekly, Vol. 1, Iss. 1059, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Isotretinoin: Optic neuritis: case report
Reactions Weekly, Vol. 1, Iss. 1435, 2013-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Imatinib: First report of optic neuritis: case report
Reactions Weekly, Vol. 1, Iss. 1152, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Interferon-: Optic neuritis in an elderly patient: case report
Reactions Weekly, Vol. 1, Iss. 1225, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bevacizumab/docetaxel: Retrobulbar optic neuritis: case report
Reactions Weekly, Vol. 1, Iss. 1428, 2012-01 ,pp. :